Literature DB >> 30560337

Coming Complications of Nonalcoholic Fatty Liver Disease: Time to GNASH Your Teeth.

Clara E Dismuke-Greer1,2, Wing-Kin Syn3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30560337     DOI： 10.1007/s10620-018-5426-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  26 in total

Review 1.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

2.  Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.

Authors:  Sahil Mittal; Yvonne H Sada; Hashem B El-Serag; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

3.  Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.

Authors:  Luca Saverio Belli; Giovanni Perricone; Rene Adam; Paolo A Cortesi; Mario Strazzabosco; Rita Facchetti; Vincent Karam; Mauro Salizzoni; Rafael Lopez Andujar; Costantino Fondevila; Paolo De Simone; Cristina Morelli; Joan Fabregat-Prous; Didier Samuel; Kosh Agarwaal; Enrique Moreno Gonzales; Ramon Charco; Krzysztof Zieniewicz; Luciano De Carlis; Christophe Duvoux
Journal:  J Hepatol       Date:  2018-06-27       Impact factor: 25.083

4.  Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

Authors:  Judith Ertle; Alexander Dechêne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer; Gernot Kaiser; Jörg F Schlaak; Guido Gerken; Wing-Kin Syn; Ali Canbay
Journal:  Int J Cancer       Date:  2011-03-14       Impact factor: 7.396

Review 5.  Extrahepatic complications of nonalcoholic fatty liver disease.

Authors:  Matthew J Armstrong; Leon A Adams; Ali Canbay; Wing-Kin Syn
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

6.  Estimating incremental costs with skew: a cautionary note.

Authors:  Linnea A Polgreen; John M Brooks
Journal:  Appl Health Econ Health Policy       Date:  2012-09-01       Impact factor: 2.561

7.  Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Duk-Hee Lee; David R Jacobs; Myron Gross; Michael Steffes
Journal:  Clin Chem       Date:  2005-05-12       Impact factor: 8.327

8.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Authors:  Zobair Younossi; Maria Stepanova; Janus P Ong; Ira M Jacobson; Elisabetta Bugianesi; Ajay Duseja; Yuichiro Eguchi; Vincent W Wong; Francesco Negro; Yusuf Yilmaz; Manuel Romero-Gomez; Jacob George; Aijaz Ahmed; Robert Wong; Issah Younossi; Mariam Ziayee; Arian Afendy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

Review 9.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

10.  Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 1-Year Postdischarge Health Care Costs.

Authors:  Kathleen B Cartmell; Clara E Dismuke; Mary Dooley; Martina Mueller; Georges J Nahhas; Graham W Warren; Peter Fallis; K Michael Cummings
Journal:  Med Care       Date:  2018-10       Impact factor: 2.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.